PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $182 | -82.9% | 71,470 | -87.4% | 0.00% | -100.0% |
| Q4 2022 | $1,063 | -99.9% | 568,568 | +93.3% | 0.00% | – |
| Q3 2022 | $756,000 | -22.3% | 294,099 | -41.7% | 0.00% | -100.0% |
| Q2 2022 | $973,000 | +107.0% | 504,221 | +218.8% | 0.00% | – |
| Q1 2022 | $470,000 | +335.2% | 158,171 | +608.9% | 0.00% | – |
| Q3 2021 | $108,000 | -93.7% | 22,313 | -91.1% | 0.00% | -100.0% |
| Q2 2021 | $1,704,000 | +2693.4% | 249,785 | +2048.3% | 0.00% | – |
| Q2 2020 | $61,000 | +17.3% | 11,627 | -29.9% | 0.00% | – |
| Q1 2020 | $52,000 | -61.8% | 16,575 | -50.9% | 0.00% | – |
| Q4 2019 | $136,000 | -87.9% | 33,771 | -83.9% | 0.00% | -100.0% |
| Q1 2019 | $1,124,000 | +708.6% | 209,760 | +1368.8% | 0.00% | – |
| Q3 2018 | $139,000 | -88.2% | 14,281 | -87.6% | 0.00% | -100.0% |
| Q2 2018 | $1,178,000 | +9.8% | 115,488 | +40.0% | 0.00% | +100.0% |
| Q1 2018 | $1,073,000 | -79.7% | 82,504 | -72.1% | 0.00% | -85.7% |
| Q4 2017 | $5,292,000 | -36.9% | 295,622 | -11.6% | 0.01% | -46.2% |
| Q3 2017 | $8,392,000 | +1542.3% | 334,353 | +1476.5% | 0.01% | +1200.0% |
| Q2 2017 | $511,000 | -96.3% | 21,209 | -97.0% | 0.00% | -96.0% |
| Q1 2017 | $13,705,000 | +2433.3% | 711,955 | +1610.7% | 0.02% | +2400.0% |
| Q3 2016 | $541,000 | -77.3% | 41,617 | -75.7% | 0.00% | -80.0% |
| Q2 2016 | $2,382,000 | +141.3% | 171,229 | +347.2% | 0.01% | +150.0% |
| Q2 2015 | $987,000 | +47.5% | 38,286 | +78.8% | 0.00% | +100.0% |
| Q1 2015 | $669,000 | – | 21,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |